Results 101 to 110 of about 1,242,848 (250)

Cost-Effectiveness of Colonoscopy for Screening: What Matters Most?

open access: yesGut and Liver
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Worldwide, population-based systematic screening programs for the disease, which is essential to address this burden, rely primarily on fecal immunochemical testing (FIT ...
Fumiaki Ishibashi, Sho Suzuki
doaj   +1 more source

Oral vancomycin solution is superior to capsule in inducing clinical biomarker and endoscopic remission in children with atypical ulcerative colitis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Atypical colitis (presenting reverse gradient colitis, backwash ileitis or rectal sparing) is associated with primary sclerosing cholangitis–ulcerative colitis (PSC). Oral vancomycin has been used to manage paediatric atypical colitis with/without confirmed PSC. Different preparations had shown different efficacy.
Laura Räisänen   +4 more
wiley   +1 more source

Inter‐ and intra‐rater reliability of two grading systems for equine gastric glandular disease

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background The recommended combined descriptive terminology scoring system for equine gastric glandular disease has poor reliability whereas a published numerical scoring system has substantial reliability. Descriptive terminology appears more affected by clinical experience than numerical scoring.
Claudia Gilders   +4 more
wiley   +1 more source

Ethnicity : UK colorectal cancer screening pilot : final report [PDF]

open access: yes
27. In summary, the overall evaluation of the UK Pilot has demonstrated that key parameters of test and programme performance observed in randomised studies of FOBt screening can be repeated in population-based pilot programmes.
Orbell, Sheina   +7 more
core  

Optimizing Colonoscopy Capacity to Maximize Colorectal Cancer Outcomes

open access: yesGastro Hep Advances
Background and Aims: Guidelines support endoscopic and stool-based testing for average-risk colorectal cancer (CRC) screening, but colonoscopy capacity is limited. With an aim to screen all eligible individuals, we identified scenarios that maximized the
A. Mark Fendrick   +6 more
doaj   +1 more source

Assessment of quality in screening colonoscopy for colorectal cancer

open access: yes, 2011
Ana Rita Gonçalves, Carlos Ferreira, António Marques, Luís Carrilho Ribeiro, José VelosaDepartment of Gastroenterology and Hepatology, Hospital Santa Maria-CHLN, Lisboa 1068, PortugalIntroduction: The ...
Marques A   +4 more
core  

Living at genetic risk: The patient experience of Lynch syndrome

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Lynch syndrome is a germline cancer predisposition syndrome caused by a variant in one of four genes. Lynch syndrome places individuals at significantly higher risk for a range of cancers, especially colorectal and endometrial. Depending on which gene is affected, the risk of ovarian, gastric, small bowel, pancreatic, biliary urothelial, brain,
Nicola Reents   +2 more
wiley   +1 more source

Waiting for diagnostic colonoscopy: a qualitative exploration of screening participants’ experiences in a FIT-based colorectal cancer screening program

open access: yes, 2018
Pia Kirkegaard,1 Adrian Edwards,1,2 Mette Bach Larsen,1 Berit Andersen1,3 1Department of Public Health Programmes, Randers Regional Hospital, Randers, Denmark; 2Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK ...
Edwards A   +3 more
core  

Observed monthly utilization of follow-up colonoscopy within 3 years after screening colonoscopy according to physician group.

open access: yes, 2013
Observed monthly utilization of follow-up colonoscopy within 3 years after screening colonoscopy according to physician group.
Michael Hoffmeister (108162)   +3 more
core   +1 more source

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy